HOME >> BIOLOGY >> NEWS
Mayo Clinic Jacksonville scientists show that specially created molecules can cross blood-brain barrier

JACKSONVILLE, Fla., July 1, 1999 -- Mayo Clinic Jacksonville scientists have shown that a specially created molecule injected into the belly of a rat can cross the nearly impassable blood-brain barrier and can stop the chemical reaction in the brain that the molecule was designed to impede.

The discovery is an amazing and unexpected finding. It could some day lead to drugs specifically created to fight disease at the molecular level, says Dr. Elliott Richelson.

Richelson and his colleagues in the Neuropsychopharmacology and Neurochemistry labs at Mayo Jacksonville and the Department of Biochemistry and Molecular Biology at Mayo Clinic Rochester described their findings in the June 8 issue of the Proceedings of the National Academy of Sciences.

Richelson has been studying neurotensin, a small piece of protein, or peptide, found in the brain and involved in pain perception and lowering body temperature. For the last few years, scientists worldwide have been testing the theory that interfering with a protein's production on a molecular level might stop it from carrying out its job in humans. Scientists were trying to interfere with protein production by creating special "antisense" molecules designed to block a cell's ability to make specific proteins.

To better understand the brain peptide he was researching, Richelson and his colleagues used peptide nucleic acids (PNAs), a new type of molecule, to create antisense compounds targeting neurotensin. When they injected the PNA antisense molecules into the brains of rats, the molecules worked. They blocked neurotensin's ability to lower body temperature and reduced its ability to block the sensation of pain.

"Then we injected PNA in the belly of the rat to see what would happen, and we got the same result," Richelson says. "Nobody had ever shown that you could inject this type of molecule or any type of antisense molecule in the belly and get a biological response in the brain."

That's importan
'"/>

Contact: Evelyn Tovar
tovar.evelyn@mayo.edu
904-953-7347
Mayo Clinic
1-Jul-1999


Page: 1 2

Related biology news :

1. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
2. Hope Clinic of Emory Vaccine Center receives CDC contract
3. Clinical judgement still counts strongly alongside genetic testing
4. Jay Levy honored with 2004 Abbott Laboratories Award in Clinical and Diagnostic Immunology
5. Melvin Weinstein wins 2004 BD Award for Research in Clinical Microbiology
6. St. Jude/Mayo Clinic study finds direct link between CBP gene and lymphoma
7. DFG to establish seven new Clinical Research Units
8. Clinical trial patients dont care about study sponsors or physician conflicts of interest
9. NIH establishes Rare Diseases Clinical Research Network
10. Grant strengthens research arm of Penn State Hershey Medical Centers ALS Clinic
11. Clinical study reports findings of combination therapy with DOXIL

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/19/2019)... ... July 19, 2019 , ... ... and Crystalline States – Insights from Synchrotron X-ray Pair Distribution (SXPDF) Studies”. The ... with Chris Benmore of Argonne National Laboratory and Gabriel de Araujo of the ...
(Date:7/17/2019)... (PRWEB) , ... July 17, ... ... the largest urology practice in the Southeast, and its acclaimed pediatric urologists ... Best Children’s Hospitals rankings. This annual recognition signifies excellence among the country’s ...
(Date:7/17/2019)... ... July 16, 2019 , ... At nearly eleven years old, Seve, ... According to his owner, in the last year or so, he was a little ... veterinarian, Dr. Cindy Echevarria of VCA University Animal Hospital in Dallas, diagnosed ...
Breaking Biology News(10 mins):
(Date:8/6/2019)... ... August 06, 2019 , ... The National Science Foundation (NSF) ... community project that will engage middle and early high school students in environmental ... Citizen Science Network for Community Environmental Assessment.” Collaborative partners presenting the authentic science ...
(Date:7/19/2019)... (PRWEB) , ... July 18, 2019 , ... ... Instrumente) announced their investment to enlarge their current piezo motion facilities in Lederhose, ... offer 3 floors for multilayer piezo ceramic assembly production in addition to general ...
(Date:7/11/2019)... , ... July 11, 2019 , ... At the most ... complimentary regenerative therapies to eight military Veterans under the R3 Heroes Program. The Veterans ... , The R3 Heroes Program allow anyone to nominate a military Veteran, teacher or ...
(Date:6/18/2019)... ... June 17, 2019 , ... IVERIC bio, ... an agreement for production and manufacturing of GMP-grade adeno-associated virus (AAV) vector for ... dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 related retinal ...
Breaking Biology Technology:
Cached News: